An Official Website of the United States Government
Supercritical Fluid Extraction of Michellamine B
- Small Business Information
-
Woman-Owned: NoMinority-Owned: NoHUBZone-Owned: No
- Phase 2
-
Fiscal Year: 1996Title: Supercritical Fluid Extraction of Michellamine BAgency: HHSContract: 1 R43 CA65368-1,Award Amount: $637,570.00
Abstract:
Michellamine B is a potential anti-HIV agent isolated from the leaves of a Cameroonian vine,Ancistrocladus korupensis, which grows in the Korup region of Cameroon. Preclinical testing ofMichellamine B by the National Cancer Institute may be adversely impacted by raw materials availability,and the inefficiencies of conventional, large-scale manufacturing processes. The latter is time, labor andmaterial-intensive, utilizes large quantities of organic solvent which can become an environmentalquagmire, and requires extracting and expensive HPLC techniques. Multiple processing steps arerequired resulting in low yields and high costs. Processing time, organic solvent usage andmanufacturing costs may be significantly reduced by the use of supercritical fluid solvents. Our specificaim to determine if Michellamine B can be isolated and purified from Ancistrocladus korupensis tissueby the use of supercritical fluid extraction and chromatographic purification techniques. Thisinvestigation should lead to the development of an improved manufacturing process for cost-effectivelyproducing large quantities of Michellamine B needed for preclinical development and clinical trials.Small Business Information at Submission:Principal Investigator:
Trevor Castor
6179326933Business Contact:
Aphios Corp.
3-E Gill Street Woburn, MA 01801EIN/Tax ID: 043205324DUNS: N/ANumber of Employees: N/AWoman-Owned: NoMinority-Owned: NoHUBZone-Owned: No
Award Information
|
Agency: Department of Health and Human Services |
Branch: N/A |
Award ID: 24929 |
Program Year/Program: 1996 / SBIR |
|
Agency Tracking Number: 24929 |
Solicitation Year: N/A |
Solicitation Topic Code: N/A |
Solicitation Number: N/A |